Immunic
IMUX
IMUX
60 hedge funds and large institutions have $37.6M invested in Immunic in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
9.09% less ownership
Funds ownership: 52.37% → 43.27% (-9.1%)
Holders
60
Holding in Top 10
–
Calls
$582K
Puts
$55K
Top Buyers
| 1 | +$472K | |
| 2 | +$426K | |
| 3 | +$377K | |
| 4 |
Squarepoint
New York
|
+$239K |
| 5 |
Renaissance Technologies
New York
|
+$229K |
Top Sellers
| 1 | -$5.04M | |
| 2 | -$1.25M | |
| 3 | -$808K | |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$582K |
| 5 |
Morgan Stanley
New York
|
-$463K |
